Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Woyach JA, Perez Burbano G, Ruppert AS, Miller C, et al. Blood 2024;143:1616-1627.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Woyach JA, Perez Burbano G, Ruppert AS, Miller C, et al. Follow-up from the A041202 study shows continued efficacy of ibrutinib regimens for older adults with CLL. Blood 2024;143:1616-1627.
PMID: 38215395